Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
13.18
+0.79 (6.38%)
At close: Oct 27, 2026, 4:00 PM EDT
13.44
+0.26 (1.97%)
After-hours: Oct 27, 2026, 7:59 PM EDT
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $1.69 billion as of October 27, 2026. Its market cap has decreased by 21.26% in one year.
Market Cap
1.69B
Enterprise Value
1.72B
1-Year Change
-21.26%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $1.69B, an increase of 185.60%. That is a compound annual growth rate of 10.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 1.69B | -26.63% |
| Dec 31, 2025 | 2.31B | 2.14% |
| Dec 31, 2024 | 2.26B | 1,162.26% |
| Dec 29, 2023 | 179.10M | -58.22% |
| Dec 30, 2022 | 428.70M | -31.15% |
| Dec 31, 2021 | 622.70M | -37.40% |
| Dec 31, 2020 | 994.70M | 35.19% |
| Dec 31, 2019 | 735.80M | 84.92% |
| Dec 31, 2018 | 397.90M | -27.59% |
| Dec 29, 2017 | 549.50M | 34.55% |
| Dec 30, 2016 | 408.40M | -12.21% |
| Dec 31, 2015 | 465.20M | -21.58% |
| Nov 13, 2015 | 593.20M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hemab Therapeutics Holdings | 1.68B |
| UroGen Pharma | 1.66B |
| Kailera Therapeutics | 1.66B |
| Stoke Therapeutics | 1.64B |
| Absci | 1.62B |
| Immunocore Holdings | 1.61B |
| Generate Biomedicines | 1.59B |
| Nuvation Bio | 1.58B |